Challenges and Approaches to Estimating Mortality Attributable to the Use of Selected Illicit Drugs
- 1 August 2001
- journal article
- Published by S. Karger AG in European Addiction Research
- Vol. 7 (3) , 104-116
- https://doi.org/10.1159/000050728
Abstract
A number of unique challenges are faced when attempting to estimate mortality attributable to illicit drugs. The hidden nature of illicit drug use creates difficulties in quantifying the prevalence of such use; identifying adverse health effects associated with exposure, and calculating the risk of these effects. The use of cohort studies of drug users allows the identification of causes of mortality associated with drug use and the determination of the risk of these causes. This risk estimate can then be used in conjunction with estimates of the prevalence of drug use to extrapolate the burden of mortality. We identify a number of such studies and present some solutions to the major challenges faced when attempting to estimate the global burden of mortality attributable to illicit drug use.Keywords
This publication has 7 references indexed in Scilit:
- MDMA (Ecstasy) neurotoxicity: assessing and communicating the risksThe Lancet, 2000
- Adverse effects of cannabisThe Lancet, 1998
- One-year mortality rates following methadone treatment dischargeDrug and Alcohol Dependence, 1998
- An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USAThe Lancet, 1997
- Tuberculosis, AIDS, and Death among Substance Abusers on Welfare in New York CityNew England Journal of Medicine, 1996
- Levels and correlates of polydrug use among heroin users and regular amphetamine usersDrug and Alcohol Dependence, 1995
- 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMAJAMA, 1987